ABCL stock news
This page provides real-time market news, earnings updates, and company announcements related to AbCellera Biologics Inc. (ABCL).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-06-27 03:36 EST
What Sparked AbCellera Biologics To Soar Over 9% After Hours
Finviz2026-02-25 08:54:44
AbCellera Biologics (ABCL) Pivots to Clinical Stage as 2025 Revenue Hits $75M
Finviz2026-02-26 19:30:41
On Friday, June 26, the U.S. Nasdaq Biotechnology Index closed up more than 2.2%, marking a record closing high for the fifth consecutive day.
华尔街见闻2026-06-26 23:16:24
ABCL stock chart
ABCL stock detailsABCL stock price change
On the last trading day, ABCL stock closed at 6.66 USD, with a price change of 10.45% for the day.
Trade spot stocks (24/7)Trade stock perps (up to 100x leverage)About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
To provide deeper liquidity, a more transparent trading experience, and greater capital efficiency, Bitget officially launched its all-new spot stock product, Bitget Stocks 2.0, on June 2, 2026.
The new product is independently issued by licensed RWA protocol Reality, with Bitget providing strategic support and asset security safeguards. This marks a major upgrade to the stock trading experience.
Bitget is moving stock trading beyond the limits of traditional trading models by fully integrating stock assets into its margin and yield ecosystem.
Learn more